QUMAS Announces New Pre-Configured Compliance Solution for Emerging Biotechnology Firms

Turnkey Solution Allows Rapid Deployment of a Comprehensive Compliance Solution
Philadelphia, PA - June 21, 2005 - At the BIO 2005 International Convention, QUMAS, the leading developer of enterprise risk and compliance management solutions, today announced the availability of BioQCompliance, a pre-configured compliance solution designed for emerging biotechnology firms. The offering will allow biotechnology firms to implement a comprehensive Life Sciences compliance solution quickly and cost effectively. BioQCompliance enables firms to meet their critical compliance needs with proven technology that has been globally deployed at a number of leading Life Sciences companies.

The BioQCompliance turnkey solution is available in packages for 25 users or 50 users. These packages include:

  • QUMAS's award winning QUMAS DocCompliance regulatory management system pre-configured according to the best regulatory practices in the biotechnology industry. The QUMAS set of best practices is based on over 10 years of experience helping organizations achieve corporate compliance and working with regulatory authorities.
  • On-site installation
  • Training
  • Support

"QUMAS has over a decade of experience providing compliance solutions to biotechnology firms ranging from pre-revenue discovery companies to some of the leading publicly traded corporations," said Paul Hands, CEO of QUMAS. "We have taken the best practices knowledge we have gained from working with such a wide range of customers and developed a compliance solution that can be up and running inside an emerging company very quickly."

Pricing and Availability

BioQCompliance is available now. To fit the needs of emerging companies, the turnkey solution is offered in a subscription licensing model for bundled packages for 25 users or 50 users.


With over a decade of experience, QUMAS is the only global compliance software company offering a complete solution to regulated industries. Recognized as the world leader in Enterprise Risk and Compliance Management, the company is a regular winner of industry awards for innovation and excellence.

QUMAS is the only vendor that offers a suite of products that enables life sciences companies to achieve complete, enterprise-wide compliance with a broad range of regulations and initiatives including 21 CFR Part 11, cGxP, Sarbanes-Oxley, eCTD, Clinical Operations, Regulatory Affairs and Change Control.

QUMAS provides highly configurable applications, ready for validation and deployment within regulated environments. Based on open systems platforms, QUMAS technology integrates seamlessly with existing corporate databases, applications, operating systems and hardware from most major vendors.

The QUMAS worldwide headquarters are located in Cork, Ireland, with U.S. headquarters in Florham Park, NJ, and satellite offices throughout the United States and Europe.

For more information visit our Web sites at www.qumas.com.

QUMAS, BioQCompliance and QUMAS DocCompliance are either registered trademarks or trademarks of QUMAS. All other trade names, trademarks, and service marks are the rightful property of their respective owners.

Michael Kane
Director of Marketing
(978) 257-2179